Bumetanide Solution For Injection 0.25Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Bumetanide: Solution for injection (0.25mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

BUMETANIDE (byoo MET a nide) is a diuretic. It helps you make more urine and to lose salt and excess water from your body. This medicine is used to treat high blood pressure, and edema or swelling from heart, kidney, or liver disease.

In-Depth Information
Select a Medication

Bumetanide 0.25mg/ml Solution for Injection

NDC: 004091412
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved





Sometimes used for but not FDA approved for the following conditions:
Ascites, Edema, Heart Failure, Hypercalcemia

Storage Information
Protect from light
Store in original container
Store at controlled room temperature (between 68 and 77 degrees F)
Bumetanide 0.25mg/ml Solution for Injection

Reported Side Effects for Bumetanide 0.25mg/ml Solution for Injection

Ringing In Ears Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Fainting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Decreased Urination Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Deafness Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Kidney Inflammation Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
High Triglycerides Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High Cholesterol Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Impotence (erectile Dysfunction) Incidence:
0.1%*
Severity: MODERATE
Onset: DELAYED
Diaphoresis Incidence:
0.1%*
Severity: MILD
Onset: EARLY
Tired Incidence:
0.1%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
0.1%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
0.1%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
0.1%*
Severity: MILD
Onset: EARLY
Balance Problems Incidence:
0.1%*
Severity: MILD
Onset: EARLY
Muscle And/Or Bone Pain Incidence:
0.2%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
0.2%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
0.2%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
0.2%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
0.2%*
Severity: MILD
Onset: EARLY
Hives Incidence:
0.2%*
Severity: MILD
Onset: RAPID
Low Platelet Count Incidence:
0.2%*
Severity: MODERATE
Onset: DELAYED
Joint Pain Incidence:
0.2%*
Severity: MILD
Onset: DELAYED
Protein In The Urine Incidence:
0.3%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
0.4%*
Severity: MILD
Onset: RAPID
Kidney Failure Incidence:
0.5%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
0.6%*
Severity: MILD
Onset: EARLY
Headache Incidence:
0.6%*
Severity: MILD
Onset: EARLY
Brain Dysfunction Incidence:
0.6%*
Severity: MODERATE
Onset: DELAYED
Glycosuria Incidence:
0.7%*
Severity: MODERATE
Onset: EARLY
Low Blood Pressure Incidence:
0.8%*
Severity: MODERATE
Onset: RAPID
Postural Low Blood Pressure Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Volume Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Lightheadedness Incidence:
1.1%*
Severity: MILD
Onset: EARLY
Muscle Cramps Incidence:
1.1%*
Severity: MILD
Onset: DELAYED
Low Calcium Levels Incidence:
2.4%*
Severity: MODERATE
Onset: DELAYED
Low Phosphate Level Incidence:
4.5%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
6.6%*
Severity: MODERATE
Onset: DELAYED
Low Blood Sodium Levels Incidence:
9.2%*
Severity: MODERATE
Onset: DELAYED
Inceased Urination Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Low Kidney Function Incidence:
10.6%*
Severity: SEVERE
Onset: DELAYED
Low Potassium Levels Incidence:
14.7%*
Severity: MODERATE
Onset: DELAYED
Low Chloride Levels Incidence:
14.9%*
Severity: MODERATE
Onset: DELAYED
High Uric Acid Level Incidence:
18.4%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Bumetanide

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.